In vivo magnetic resonance imaging and spectroscopy in pharmacological research: assessment of morphological, physiological and metabolic effects of drugs
- 31 October 1995
- journal article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 3 (5) , 255-264
- https://doi.org/10.1016/0928-0987(95)00012-3
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Comparison of diffusion‐weighted MRI with changes in cell volume in a rat model of brain injuryNMR in Biomedicine, 1994
- Diffusion- and T2-weighted imaging: Evaluation of oedema reduction in focal cerebral ischaemia by the calcium and serotonin antagonist levemopamilMagnetic Resonance Imaging, 1993
- Characterization of the Cerebroprotective Efficacy of the Competitive NMDA Receptor Antagonist CGP40116 in a Rat Model of Focal Cerebral Ischemia: An in vivo Magnetic Resonance Imaging StudyJournal of Cerebral Blood Flow & Metabolism, 1993
- Effect of Spirapril on Left Ventricular Hypertrophy Due to Volume Overload in RatsJournal of Cardiovascular Pharmacology, 1992
- New developments in cardiovascular magnetic resonance imaging and spectroscopyTrends in Pharmacological Sciences, 1991
- Noninvasive determination of regional cerebral blood flow in rats using dynamic imaging with Gd(DTPA)Magnetic Resonance in Medicine, 1991
- Experimental Studies with Isradipine in StrokeDrugs, 1990
- Treatment of hypertension with isradipine reduces infarct size following stroke in laboratory animalsThe American Journal of Medicine, 1989
- Calcium antagonists reduce the extent of infarction in rat middle cerebral artery occlusion model as determined by quantitative magnetic resonance imaging.Stroke, 1986
- Thresholds in cerebral ischemia - the ischemic penumbra.Stroke, 1981